Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 20, 2024 (GLOBE NEWSWIRE) -- According to Transparency Market Research (TMR), the global prefilled syringes market (プレフィルドシリンジ市場)value is estimated to exceed US$ 35.7 Billion by the end of 2031 from US$ 13.6 Billion in 2021 at a fast-paced CAGR of 10.1% during the forecast period.
Pre-filled syringe is a type of syringe that has medicine in it and comes with a needle attached. This makes it easier for individuals and medical professionals to administer injections without needing to measure the medicine.
Prefilled syringes are designed to streamline the injection process. They are preloaded with a specific dosage of medication and an attached needle, thus eliminating the need for manual measurement and preparation.
This design not only enhances convenience but also significantly reduces the risk of dosage errors, making it a preferred choice in the healthcare industry.
Rise in demand for efficient and easy-to-use drug delivery devices and growing efforts by medical professionals to mitigate human errors at medical facilities are anticipated to drive prefilled syringes market growth.
Request a PDF Sample of this Report Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1131
As a result, key players striving to offer precise prefilled syringes that would make self-injecting safer and more convenient for patients.
In 2022, Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of injection, primary container, and infusion therapy devices, launched a pre-fillable polymer syringe for low-dose applications such as ophthalmic drugs.
Prefilled Syringes Market Key Takeaways
- Increase in Prevalence of Chronic Diseases
- Continuous Efforts by Key Players
Chronic diseases such as diabetes, cardiovascular diseases, rheumatoid arthritis, and autoimmune disorders need continuous and precise medication administration. Prefilled syringes are developed with the aim of offering precise dosages, which is essential in managing these diseases effectively. For instance, a diabetic patient typically requires insulin injections regularly and prefilled syringes make sure that the correct dose is administered each time, mitigating the risk of errors associated with manual preparation.
This precision in dosage helps in maintaining the patient's health and managing their conditions more effectively. Thus, individuals diagnosed with diabetes generally utilize prefilled syringes in order to administer multiple doses of insulin precisely.
Rise in prevalence of diabetes and growing demand for effective and safer insulin delivery devices are expected to boost the prefilled syringes market size during the forecast period.
Leading pharmaceutical and medical device manufacturers are working on introducing innovative prefilled syringes that include advanced technologies and offer enhanced safety, convenience, and efficacy.
- In October 2022, Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, launched Succinylcholine Chloride Injection, USP, in a prefilled syringe (PFS) form.
The 100mg/5mL PFS has been launched in the U.S. and is the first FDA-approved PFS for this product to be introduced in the market. Succinylcholine chloride is an important medicine used in hospitals for general anesthesia, to facilitate tracheal intubation, and provide muscle relaxation during surgery or mechanical ventilation.
Prefilled Syringes Market Regional Insights
- North America dominated the market share in 2021
- Asia Pacific estimated to record rapid growth during the forecast period
North America accounted for the largest market value in 2021. The region is likely to maintain its dominant position during the forecast period.
Rise in adoption of prefilled injectable devices by medical professionals, presence of major market players in the region owing to several supportive government policies, increase in prevalence of chronic disorders owing to rising aging population and lifestyle changes, surge in demand for convenient drug delivery methods, and continuous improvements in syringe design and manufacturing processes that enhance safety are some of the factors augmenting the prefilled syringes market share of North America.
As per Pan America Health Organization Report 2022, at least 62 million people live with diabetes in America, and the number is expected to be much higher, given that around 40% of those with the disease are unaware that they have the condition.
Asia Pacific is likely to record fast-paced market growth in the next few years.
Surge in investment in healthcare infrastructure and services, growth in aging population, particularly in countries such as Japan and China, significant advancements in medical technology, and rise in awareness about the benefits of self-administration of medications are some of the factors expected to create significant prefilled syringes market opportunities in Asia Pacific.
Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1131
Key Players in Prefilled Syringes Market
B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson, and Company (BD), Catalent, Inc., Elcam Medical, Gerresheimer AG, Nipro Corporation, SCHOTT AG, Terumo Corporation, Vetter Pharma, Weigao Group, and West Pharmaceutical Services, Inc. are some of the leading key players operating in the global prefilled syringes industry.
Prominent prefilled syringes market manufacturers are working on unveiling prefilled syringes with enhanced needle safety mechanisms that would lower the risk of needle stick injuries.
They are also incorporating advanced materials in their products in order to ensure better compatibility with a broader range of medications, including biologics and vaccines.
- In July 2024, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) had approved the Vabysmo (faricimab-svoa) 6.0 mg single-dose prefilled syringe (PFS) for usage in the treatment of wet, or neovascular, age-related macular degeneration (AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO)
Vabysmo PFS would offer the same medicine as the currently available Vabysmo vials in an alternative, ready-to-use format. However, it is anticipated to be the first and only bispecific antibody approved for the eye and has demonstrated rapid and robust vision improvements and retinal drying in wet AMD, DME, and RVO.
Prefilled Syringes Market Segmentation
Type
- Safety Syringes
- Conventional Syringes
Design
- Single Chamber
- Dual Chamber
- Multiple Chamber
Material
- Glass
- Plastic
Application
- Chronic Disease Treatment Syringes
- Vaccine Syringes
- Anticoagulant Syringes
- Acute Care and Specialty Syringes
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- E-commerce
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=1131<ype=S
More Trending Reports by Transparency Market Research –
- Healthcare Automation Market – The Global Healthcare Automation Market Size (ヘルスケアオートメーション市場) is Worth USD 88.9 Billion in 2028 Growing at a CAGR of 8.4%, TMR Study
- Durable Medical Equipment (DME) Market – The Global Durable Medical Equipment Market (耐久医療機器市場)to Reach US$ 261 Billion by 2027, TMR Study
- Lucid Dreaming Devices Market – The Global Lucid Dreaming Devices Market (明晰夢装置市場) is expected reach US$ 196.8 Million by the end of 2034
- Low Endotoxin Gelatin Market - The Global Low Endotoxin Gelatin Market (低エンドトキシンゼラチン市場)is expected to grow at a CAGR of 6.4% from 2024 to 2034.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
